Previous Close | 52.80 |
Open | 53.03 |
Bid | 52.43 x 800 |
Ask | 52.39 x 1100 |
Day's Range | 52.33 - 53.42 |
52 Week Range | 39.35 - 57.65 |
Volume | |
Avg. Volume | 13,663,190 |
Market Cap | 106.236B |
Beta (5Y Monthly) | 0.46 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.25 |
Earnings Date | Oct 31, 2024 |
Forward Dividend & Yield | 2.40 (4.55%) |
Ex-Dividend Date | Oct 04, 2024 |
1y Target Est | 52.77 |
While the recent spate of positive regulatory updates boosts Bristol Myers, we will advise a wait-and-watch strategy.
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
We recently compiled a list of the 10 Buzzing AI Health Stocks. In this article, we are going to take a look at where Bristol-Myers Squibb Company (NYSE:BMY) stands against the other buzzing AI health stocks. The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are […]